These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3072664)
21. Current trends in the pharmacotherapy for peptic ulcer disease. Hixson LJ; Kelley CL; Jones WN; Tuohy CD Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429 [TBL] [Abstract][Full Text] [Related]
22. Role of protective drugs in the prevention of ulcer relapse. Ota S; Terano A J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147 [TBL] [Abstract][Full Text] [Related]
23. Therapy of gastrointestinal ulcers. Dowling PM Can Vet J; 1995 May; 36(5):276-7. PubMed ID: 7773915 [No Abstract] [Full Text] [Related]
24. The other option in peptic ulcer therapy. Halter F S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932 [TBL] [Abstract][Full Text] [Related]
25. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. Soll AH JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244 [TBL] [Abstract][Full Text] [Related]
26. [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Grigor'ev PIa; Isakov VA; Iakovenko EP Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485 [No Abstract] [Full Text] [Related]
27. Critical issues in the pathophysiology and management of peptic ulcer disease. Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166 [TBL] [Abstract][Full Text] [Related]
28. Advances in the treatment of peptic ulcer disease. Camara DS Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333 [No Abstract] [Full Text] [Related]
29. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Wagstaff AJ; Benfield P; Monk JP Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124 [TBL] [Abstract][Full Text] [Related]
30. Overview of medical therapy of peptic ulcer disease. Freston JW Gastroenterol Clin North Am; 1990 Mar; 19(1):121-40. PubMed ID: 2184124 [TBL] [Abstract][Full Text] [Related]
31. The medical management of peptic ulcer. Shearman DJ; Hetzel D Annu Rev Med; 1979; 30():61-79. PubMed ID: 45409 [No Abstract] [Full Text] [Related]
32. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer]. Belousov IuB; Karpov OI; Belousov DIu; Beketov AS Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971 [No Abstract] [Full Text] [Related]
33. Drugs for treatment of peptic ulcers. Med Lett Drugs Ther; 1997 Jan; 39(991):1-4. PubMed ID: 8996458 [No Abstract] [Full Text] [Related]
35. Recent advances in the treatment of digestive diseases. Sun HS J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540 [TBL] [Abstract][Full Text] [Related]
36. Treatment of the gastric stump ulcer: an open study with five drugs. Janke A; Stasiewicz J; Namiot Z; Szalaj W Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913 [TBL] [Abstract][Full Text] [Related]
37. Longer relapse-free period after sucralfate than after H2-blocker treatment of duodenal and gastric ulcers. Domschke S; Domschke W Am J Med; 1991 Aug; 91(2A):74S-83S. PubMed ID: 1679297 [TBL] [Abstract][Full Text] [Related]
38. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842 [TBL] [Abstract][Full Text] [Related]
39. Anti-ulcer therapy. Past to present. Bettarello A Dig Dis Sci; 1985 Nov; 30(11 Suppl):36S-42S. PubMed ID: 2865091 [TBL] [Abstract][Full Text] [Related]